go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Montana rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $562,341 · 10th–90th $501,187$1,023,2930%50%10th90th$562,341Professionalmedian $562,341 · 10th–90th $501,187$676,0830%50%10th90th$562,341$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$616,595.00
Typical High
$676,082.98
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
MountainHealth Co-op
Setting
Facility
Modifier
Global
Typical Low
$501,187.23
Median
$501,187.23
Typical High
$933,254.30
MountainHealth Co-op
Setting
Professional
Modifier
Global
Typical Low
$501,187.23
Median
$501,187.23
Typical High
$933,254.30
Providence
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$645,654.23
Typical High
$1,202,264.43
Providence
Setting
Professional
Modifier
Global
Typical Low
$79.43
Median
$616,595.00
Typical High
$794,328.23
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$436,515.83
Typical High
$512,861.38